Poor
Not Aligned
Patient Risk:
Moderate
Summary
Only the IL-17A mechanism claims are supported by the provided label excerpts; most efficacy, diet/gut microbiome, contraindication/diet interaction, and safety-related claims are not supported by the supplied label text, and key FDA label sections needed for comprehensive compliance are not provided.
Category Scores
Accurate Statements
Cosentyx (secukinumab) works by targeting and blocking the activity of interleukin-17A (IL-17A).
Supported by 12.1 Mechanism of Action (selectively binds IL-17A and inhibits its interaction with the IL-17 receptor).
By inhibiting IL-17A, Cosentyx reduces inflammation.
Supported by 12.1 Mechanism of Action (inhibits release of proinflammatory cytokines and chemokines).
Unsupported Statements
By inhibiting IL-17A, Cosentyx slows down disease progression.
No provided label text states that IL-17A inhibition slows disease progression.
An imbalance of gut bacteria (dysbiosis) can lead to reduced efficacy of biologic medications, including Cosentyx.
No provided label text discusses dysbiosis/gut microbiome effects on efficacy.
An imbalance of gut bacteria (dysbiosis) can lead to increased side effects of biologic medications, including Cosentyx.
No provided label text discusses dysbiosis/gut microbiome effects on adverse effects.
There are no specific foods that are contraindicated with Cosentyx.
No provided label text addresses food contraindications.
Certain foods can interact with Cosentyx or exacerbate side effects.
No provided label text addresses food interactions or diet-related side effects.
Consuming high amounts of sugar can lead to inflammation and worsen symptoms.
No provided label text addresses sugar intake or symptom worsening.
Processed meats contain advanced glycation end (AGE) products that can stimulate inflammation.
No provided label text addresses AGEs, processed meats, or inflammation mechanisms related to diet.
Fried foods are high in omega-6 fatty acids, which can promote inflammation.
No provided label text addresses omega-6 fatty acids, fried foods, or inflammation related to diet.
Some people with psoriasis may experience worsening symptoms after consuming dairy products, particularly those high in lactose.
No provided label text addresses dairy/lactose and psoriasis symptom changes.
A small percentage of people with psoriasis may experience symptoms after consuming gluten (wheat, barley, and rye).
No provided label text addresses gluten and psoriasis symptom changes.
Fatty fish are rich in omega-3 fatty acids, which can help reduce inflammation.
No provided label text addresses omega-3 intake or fatty fish for inflammation related to Cosentyx.
Leafy greens are rich in antioxidants and fiber, which can help maintain a healthy gut microbiome.
No provided label text addresses antioxidants/fiber or dietary effects on gut microbiome.
Berries are rich in antioxidants and fiber, which can help reduce inflammation.
No provided label text addresses berries or dietary effects on inflammation.
Nuts and seeds are rich in healthy fats and fiber, which can help maintain a healthy gut microbiome.
No provided label text addresses nuts/seeds or dietary effects on gut microbiome.
Maintaining a healthy gut microbiome can improve the effectiveness of Cosentyx.
No provided label text links gut microbiome status to Cosentyx effectiveness.
Maintaining a healthy gut microbiome can reduce the risk of side effects such as diarrhea and abdominal pain.
No provided label text links gut microbiome status to risk reduction for specific adverse reactions.
Maintaining a healthy gut microbiome can promote overall health and well-being.
No provided label text supports this wellness/diet claim.
A high-fiber diet can help maintain a healthy gut microbiome.
No provided label text addresses high-fiber diets and gut microbiome in relation to Cosentyx.
A gluten-free diet can be taken with Cosentyx.
No provided label text addresses gluten-free diets in relation to Cosentyx.
A dairy-free diet can be taken with Cosentyx.
No provided label text addresses dairy-free diets in relation to Cosentyx.
A vegan diet can be taken with Cosentyx.
No provided label text addresses vegan diets in relation to Cosentyx.
A probiotic supplement can be taken with Cosentyx.
No provided label text addresses probiotic supplements or their compatibility with Cosentyx.
Contradictions
Important Omissions
Key FDA label sections needed to validate safety/label compliance: Contraindications, Boxed Warning, Warnings and Precautions content, Dosage and Administration details, and specific population guidance (e.g., pregnancy/lactation/pediatrics).
Importance:
High
If making claims about 'certain foods' interacting with Cosentyx, the label excerpt provided only discusses 'Certain CYP450 Substrates' as the drug interaction mechanism; dietary/fiber/food interaction details are not provided.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Diet/gut-microbiome and specific intake claims are not supported by the provided label excerpts, which may mislead patients about factors affecting efficacy and adverse effects. The provided excerpts also do not include key contraindications/warnings/dosing/pregnancy/pediatric content needed to confirm safe labeling beyond the IL-17A mechanism.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
Most claims (diet/food interactions, dysbiosis effects, and disease progression assertions) are absent from the provided FDA label excerpts, and essential label sections were not provided to verify safety content.
Suggested Improvement
Restrict statements to label-supported content from the provided excerpts (e.g., IL-17A mechanism). Remove or qualify diet/gut-microbiome efficacy and side-effect risk claims unless supported by the actual FDA label text, and provide/limit evaluation to the missing sections if full compliance assessment is required.